|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/711 | |||
| A61P 27/02 |
| (11) | Number of the document | 2086503 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07868629.2 |
| Date of filing the European patent application | 2007-10-31 | |
| (97) | Date of publication of the European application | 2009-08-12 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/083103 |
| Date | 2007-10-31 |
| (87) | Number | WO 2008/057867 |
| Date | 2008-05-15 |
| (30) | Number | Date | Country code |
| 556503 | 2006-11-03 | US |
| (72) |
TROGDEN, John T., US
LYONS, Robert T., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | SUSTAINED RELEASE DRUG DELIVERY SYSTEMS COMPRISING A WATER SOLUBLE THERAPEUTIC AGENT AND A RELEASE MODIFIER |
| SUSTAINED RELEASE DRUG DELIVERY SYSTEMS COMPRISING A WATER SOLUBLE THERAPEUTIC AGENT AND A RELEASE MODIFIER |